Brighton Jones’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
Brighton Jones's KURA Position: Q3 2026 in Review
Brighton Jones reduced its Kura Oncology (KURA) stake by 23% in Q3 2026, selling an estimated $57.9K and leaving 17,773 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.
Brighton Jones first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. The position peaked at $252K in Q2 2026. 192 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- Brighton Jones held 17,773 shares of Kura Oncology worth $190K as of Q3 2026.
- Brighton Jones sold 5,174 Kura Oncology shares in Q3 2026, an estimated $57.9K.
- Kura Oncology made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1279 holding.
- Brighton Jones first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
- Brighton Jones's Kura Oncology position peaked at $252K in Q2 2026.
- 192 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.